Flagship explainer
What drives BioCorRx Inc.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$3.4M | FY2025 |
| |
| Income before tax | −$3.5M | FY2025 |
|
| Operating income | −$4.8M | FY2025 |
|
| $797244 | FY2025 |
| |
| Ending assets | $2.1M | FY2025 |
|
| Beginning assets | $385941 | FY2024 |
|
| −$11.2M | FY2025 |
| |
| −$12.1M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001477932-25-002219
- SEC filingFiling detailsAccession 0001477932-26-001807